Adult Diffuse Astrocytoma Completed Phase 1 / 2 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0029697 (Adult Diffuse Astrocytoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00112736Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaTreatment